Preclinical characterisation of (111)In-DTPA-trastuzumab

Trastuzumab (Herceptin®) is a recombinant humanised IgG1 monoclonal antibody against the human epidermal growth factor receptor 2 (HER2), used for metastatic breast cancer treatment. Radiolabelled trastuzumab may have several future applications for diagnostic use. The aim of the present study was t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lub-de Hooge, Marjolijn N, Kosterink, Jos G W, Perik, Patrick J, Nijnuis, Hugo, Tran, Ly, Bart, Joost, Suurmeijer, Albert J H, de Jong, Steven, Jager, Pieter L, de Vries, Elisabeth G E
Formato: Artigo
Idioma:Inglês
Publicado em: 2004
Assuntos:
Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1575276/
https://ncbi.nlm.nih.gov/pubmed/15289297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705915
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados